Strong selective pressure for evolution of an Epstein-Barr virus LMP2B homologue in the rhesus lymphocryptovirus

Journal of Virology

Volumn 73, Issue 10, 1999, Pages 8867-8872

  Rivailler, Pierre ^a   Quink, Carol ^a   Wang, Fred ^a,b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b CHANNING LABORATORY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LATENT MEMBRANE PROTEIN 1;

ARTICLE; BABOON; EPSTEIN BARR VIRUS; EVOLUTION; EXON; GENETIC CONSERVATION; HERPES VIRUS; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; RHESUS MONKEY; SEQUENCE HOMOLOGY; VIRUS GENOME;

EID: 0032844938     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.73.10.8867-8872.1999     Document Type: Article

References (33)

1. Ablashi, D. V., P. Gerber, and J. Easton. 1979. Oncogenic herpesviruses of nonhuman primates. Comp. Immunol. Microbiol. Infect. Dis. 2:229-241.
2. Ambinder, R. F., and R. B. Mann. 1994. Detection and characterization of Epstein-Barr virus in clinical specimens. Am. J. Pathol. 145:239-252.
3. Blake, N. W., A. Moghaddam, P. Rao, A. Kaur, R. Glickman, Y.-G. Cho, A. Marchini, T. Haigh, R. P. Johnson, A. B. Rickinson, and F. Wang. 1999. Inhibition of antigen presentation by the glycine/alanine repeat domain is not conserved in simian homologues of the Epstein-Barr virus nuclear antigen 1. J. Virol. 73:7381-7389.
4. 3a.Classiflcation and Secondary Structure Prediction of Membrane Proteins Website. 19 September 1998, revision date. [Online.] SOSUI software, version 1.0. Department of Biotechnology, Tokyo University of Agriculture and Technology, Tokyo, Japan. http://www.tuat.ac.jp/∼mitaku/adv_sosui/. [9 August 1999, date last accessed.]
5. Daibata, M., R. E. Humphreys, K. Takada, and T. Sairenji. 1990. Activation of latent EBV via anti-IgG-triggered, second messenger pathways in the Burkitt's lymphoma cell line Akata. J. Immunol. 144:4788-4793.
6. Frank, A., W. A. Andiman, and G. Miller. 1976. Epstein-Barr virus and nonhuman primates: natural and experimental infection. Adv. Cancer Res. 23:171-201.
7. Franken, M., B. Annis, A. N. Ali, and F. Wang. 1995. 5′ Coding and regulatory region sequence divergence with conserved function of the Epstein-Barr virus LMP2A homolog in herpesvirus papio. J. Virol. 69:8011-8019.
8. Franken, M., O. Devergne, M. Rosenzweig, B. Annis, E. Kieff, and F. Wang. 1996. Comparative analysis identifies conserved tumor necrosis factor receptor-associated factor 3 binding sites in the human and simian Epstein-Barr virus oncogene LMP1. J. Virol. 70:7819-7826.
9. Fruehling, S., R. Swart, K. M. Dolwick, E. Kremmer, and R. Longnecker. 1998. Tyrosine 112 of latent membrane protein 2A is essential for protein tyrosine kinase loading and regulation of Epstein-Barr virus latency. J. Virol. 72:7796-7806.
10. Fuentes-Panana, E. M., S. Swaminathan, and P. D. Ling. 1999. Transcriptional activation signals found in the Epstein-Barr virus (EBV) latency C promoter are conserved in the latency C promoter sequences from baboon and rhesus monkey EBV-like lymphocryptoviruses (cercopithicine herpesviruses 12 and 15). J. Virol. 73:826-833.
11. Gerber, P., S. S. Kalter, G. Schidlovsky, W. D. Peterson, Jr., and M. D. Daniel. 1977. Biologic and antigenic characteristics of Epstein-Barr virus-related herpesviruses of chimpanzees and baboons. Int. J. Cancer 20:448-459.
12. Gordadze, A., and P. Ling. Rhesus LCV EBNA-2 and EBNA-LP sequences. Unpublished data.
13. Grossman, S. R., E. Johannsen, X. Tong, R. Yalamanchili, and E. Kieff. 1994. The Epstein-Barr virus nuclear antigen 2 transactivator is directed to response elements by the J kappa recombination signal binding protein. Proc. Natl. Acad. Sci. USA 91:7568-7572.
14. Henkel, T., P. D. Ling, S. D. Hayward, and M. G. Peterson. 1994. Mediation of Epstein-Bair virus EBNA2 transactivation by recombination signal-binding protein J kappa. Science 265:92-95.
15. Jiang, H., and F. Wang. Rhesus LCV EBERs sequence. Unpublished data.
16. Jiang, H., and F. Wang. Rhesus LCV EBNA-3A, -3B, -3C sequence. Unpublished data.
17. Johannsen, E., E. Koh, G. Mosialos, X. Tong, E. Kieff, and S. R. Grossman. 1995. Epstein-Barr virus nuclear protein 2 transactivation of the latent membrane protein 1 promoter is mediated by J kappa and PU.1. J. Virol. 69: 253-262.
18. Kieff, E. 1996. Epstein-Barr virus and its replication, p. 2343-2396. In D. Knipe, B. Fields, and F. Howley (ed.), Fields virology. Raven Press, Philadelphia, Pa.
19. Laux, G., B. Adam, L. J. Strobl, and F. Moreau-Gachelin. 1994. The Spi-1/PU.1 and Spi-B ets family transcription factors and the recombination signal binding protein RBP-J kappa interact with an Epstein-Barr virus nuclear antigen 2 responsive cis-element. EMBO J. 13:5624-5632.
20. Laux, G., A. Economou, and P. J. Farrell. 1989. The terminal protein gene 2 of Epstein-Barr virus is transcribed from a bidirectional latent promoter region. J. Gen. Virol. 70:3079-3084.
21. Laux, G., M. Perricaudet, and P. J. Farrell. 1988. A spliced Epstein-Barr virus gene expressed in immortalized lymphocytes is created by circularization of the linear viral genome. EMBO J. 7:769-774.
22. Ling, P. D., J. J. Ryon, and S. D. Hayward. 1993. EBNA-2 of herpesvirus papio diverges significantly from the type A and type B EBNA-2 proteins of Epstein-Barr virus but retains an efficient transactivation domain with a conserved hydrophobic motif. J. Virol. 67:2990-3003.
23. Longnecker, R., C. L. Miller, X.-Q. Miao, A. Marchini, and E. Kieff. 1992. The only domain which distinguishes Epstein-Barr virus latent membrane protein 2A (LMP2A) from LMP2B is dispensable for lymphocyte infection and growth transformation in vitro; LMP2A is therefore nonessential. J. Virol. 66:6461-6469.
24. Longnecker, R., C. L. Miller, B. Tomkinson, X.-Q. Miao, and E. Kieff. 1993. Deletion of DNA encoding the first five transmembrane domains of Epstein-Barr virus latent membrane proteins 2A and 2B. J. Virol. 67:5068-5074.
25. Miller, C. L., A. L. Burkhardt, J. H. Lee, B. Stealey, R. Longnecker, J. B. Bolen, and E. Kieff. 1995. Integral membrane protein 2 of Epstein-Barr virus regulates reactivation from latency through dominant negative effects on protein-tyrosine kinases. Immunity 2:155-166.
26. Miller, C. L., J. H. Lee, E. Kieff, and R. Longnecker. 1994. An integral membrane protein (LMP2) blocks reactivation of Epstein-Barr virus from latency following surface immunoglobulin crosslinking. Proc. Natl. Acad. Sci. USA 91:772-776.
27. Moghaddam, A., M. Rosenzweig, D. Lee-Parritz, B. Annis, R. P. Johnson, and F. Wang. 1997. An animal model for acute and persistent Epstein-Barr virus infection. Science 274:2030-2033.
28. Ruf, I. K., A. Moghaddam, F. Wang, and J. Sample. 1999. Mechanisms that regulate Epstein-Barr virus EBNA-1 gene transcription during restricted latency are conserved among lymphocryptoviruses of Old World primates. J. Virol. 73:1980-1989.
29. Sample, J., D. Liebowitz, and E. Kieff. 1989. Two related Epstein-Barr virus membrane proteins are encoded by separate genes. J. Virol. 63:933-937.
30. Thorley-Lawson, D. A., E. M. Miyashita, and G. Khan. 1996. Epstein-Barr virus and the B cell: that's all it takes. Trends Microbiol. 4:204-208.
31. Tovey, M. G., G. Lenoir, and J. Begon-Lours. 1978. Activation of latent Epstein-Barr virus by antibody to human IgM. Nature 276:270-272.
32. Wang, F. Rhesus LCV LMP2-A promoter sequence. Unpublished data.
33. Yates, J. L., S. M. Camiolo, S. Ali, and A. Ying. 1996. Comparison of the EBNA1 proteins of Epstein-Barr virus and herpesvirus papio in sequence and function. Virology 222:1-13.